Gloria M. Reeves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gloria M. Reeves has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Teodor Tudorel Postolache
Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA
5 shared publications Soren Snitker
Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA
4 shared publications- Bruno J. Anthony
Department of Psychiatry University of Colorado School of Medicine Aurora Colorado USA
3 shared publications - Mark A. Riddle
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
3 shared publications Patricia Langenberg
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
3 shared publicationsEmily Kline
Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, United States
2 shared publications
Latest Publications
- 21 August 2017
- Published by Wiley
- p. 411-432
Pharmacotherapy of Disruptive and Impulse Control Disorders
- 21 August 2017
- Published by Wiley
- p. 411-432
Pharmacotherapy of Disruptive and Impulse Control Disorders
- 1 December 2015
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 203 (12) , 896-900
The Family Value of Information, Community Support, and Experience Study
The Patient Protection and Affordable Care Act focuses on improving consumer engagement and patient-centered care. This article describes the design and rationale of a study targeting family engagement in pediatric mental health services. The study is a 90-day randomized trial of a telephone-delivered Family Navigator services versus usual care for parents of Medicaid-insured youth younger than 13 years with serious mental illness. Youth are identified through a pediatric antipsychotic medication preauthorization program. Family Navigators offer peer support to empower and engage parents in their child's recovery. Outcomes include parent report of empowerment, social support, satisfaction with child mental health services, and child functioning as well as claims-based measures of psychotherapy service utilization and antipsychotic medication dosage. The focus on family-centered care in this study is strongly supported by the active role of consumers in study design and implementation.
- 1 December 2015
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 203 (12) , 896-900
The Family Value of Information, Community Support, and Experience Study
The Patient Protection and Affordable Care Act focuses on improving consumer engagement and patient-centered care. This article describes the design and rationale of a study targeting family engagement in pediatric mental health services. The study is a 90-day randomized trial of a telephone-delivered Family Navigator services versus usual care for parents of Medicaid-insured youth younger than 13 years with serious mental illness. Youth are identified through a pediatric antipsychotic medication preauthorization program. Family Navigators offer peer support to empower and engage parents in their child's recovery. Outcomes include parent report of empowerment, social support, satisfaction with child mental health services, and child functioning as well as claims-based measures of psychotherapy service utilization and antipsychotic medication dosage. The focus on family-centered care in this study is strongly supported by the active role of consumers in study design and implementation.
- 1 June 2015
- Published by Springer Nature in Current Addiction Reports
- Vol. 2 (2) , 130-140
Integrative Model of the Relationship Between Sleep Problems and Risk for Youth Substance Use
- 1 June 2015
- Published by Springer Nature in Current Addiction Reports
- Vol. 2 (2) , 130-140
Integrative Model of the Relationship Between Sleep Problems and Risk for Youth Substance Use
- 1 March 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1-3) , 79-85
Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis
- 1 March 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1-3) , 79-85
Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis
- 15 September 2014
- Published by Springer Nature
- p. 361-380
Schizophrenia
- 1 August 2013
- Vol. 24 (2) , 371-90, vii
Pediatric psychopharmacology in primary care: a conceptual framework.
In a 2009 policy statement focused on children's mental health, the American Academy of Pediatrics recommended that pediatric primary care physicians achieve competence in initiating care for children with attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and substance use/abuse. Because treatment for 3 of these conditions--ADHD, anxiety, and depression--may, under certain conditions, include medication, the primary purpose of this article is to offer guidance to assist primary care physicians in decision-making about their use of psychotropic medications for these conditions. A few medications with proven efficacy and safety are emphasized. Secondarily, other medications that may be useful for other disorders are noted.
- 1 August 2013
- Vol. 24 (2) , 371-90, vii
Pediatric psychopharmacology in primary care: a conceptual framework.
In a 2009 policy statement focused on children's mental health, the American Academy of Pediatrics recommended that pediatric primary care physicians achieve competence in initiating care for children with attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and substance use/abuse. Because treatment for 3 of these conditions--ADHD, anxiety, and depression--may, under certain conditions, include medication, the primary purpose of this article is to offer guidance to assist primary care physicians in decision-making about their use of psychotropic medications for these conditions. A few medications with proven efficacy and safety are emphasized. Secondarily, other medications that may be useful for other disorders are noted.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 1, 73
A Positive Association between T. gondii Seropositivity and Obesity
Obesity is a global public health problem that is linked with morbidity, mortality, and functional limitations and has limited options for sustained interventions. Novel targets for prevention and intervention require further research into the pathogenesis of obesity. Consistently, elevated markers of inflammation have been reported in association with obesity, but their causes and consequences are not well understood. An emerging field of research has investigated the association of infections and environmental pathogens with obesity, potential causes of low grade inflammation that may mediate obesity risk. In this study, we estimate the possible association between Toxoplasma gondii (T. gondii) infection and obesity in a sample of 999 psychiatrically healthy adults. Individuals with psychiatric conditions, including personality disorders, were excluded because of the association between positive serology to T. gondii and various forms of serious mental illness that have a strong association with obesity. In our sample, individuals with positive T. gondii serology had twice the odds of being obese compared to seronegative individuals (p = 0.01). Further, individuals who were obese had significant higher T. gondii IgG titers compared to individuals who were non-obese. Latent T. gondii infection is very common worldwide, so potential public health interventions related to this parasite can have a high impact on associated health concerns.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 1, 73
Open AccessA Positive Association between T. gondii Seropositivity and Obesity
Obesity is a global public health problem that is linked with morbidity, mortality, and functional limitations and has limited options for sustained interventions. Novel targets for prevention and intervention require further research into the pathogenesis of obesity. Consistently, elevated markers of inflammation have been reported in association with obesity, but their causes and consequences are not well understood. An emerging field of research has investigated the association of infections and environmental pathogens with obesity, potential causes of low grade inflammation that may mediate obesity risk. In this study, we estimate the possible association between Toxoplasma gondii (T. gondii) infection and obesity in a sample of 999 psychiatrically healthy adults. Individuals with psychiatric conditions, including personality disorders, were excluded because of the association between positive serology to T. gondii and various forms of serious mental illness that have a strong association with obesity. In our sample, individuals with positive T. gondii serology had twice the odds of being obese compared to seronegative individuals (p = 0.01). Further, individuals who were obese had significant higher T. gondii IgG titers compared to individuals who were non-obese. Latent T. gondii infection is very common worldwide, so potential public health interventions related to this parasite can have a high impact on associated health concerns.
- Open Access
- 1 January 2013
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
- Vol. 7 (1) , 31
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods
Youth with serious mental illness may experience improved psychiatric stability with second generation antipsychotic (SGA) medication treatment, but unfortunately may also experience unhealthy weight gain adverse events. Research on weight loss strategies for youth who require ongoing antipsychotic treatment is quite limited. The purpose of this paper is to present the design, methods, and rationale of the Improving Metabolic Parameters in Antipsychotic Child Treatment (IMPACT) study, a federally funded, randomized trial comparing two pharmacologic strategies against a control condition to manage SGA-related weight gain.
- 1 January 2013
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
- Vol. 7 (1) , 31
Open AccessImproving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods
Youth with serious mental illness may experience improved psychiatric stability with second generation antipsychotic (SGA) medication treatment, but unfortunately may also experience unhealthy weight gain adverse events. Research on weight loss strategies for youth who require ongoing antipsychotic treatment is quite limited. The purpose of this paper is to present the design, methods, and rationale of the Improving Metabolic Parameters in Antipsychotic Child Treatment (IMPACT) study, a federally funded, randomized trial comparing two pharmacologic strategies against a control condition to manage SGA-related weight gain.
- 1 April 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 138 (1-2) , 123-127
Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes
- 1 April 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 138 (1-2) , 123-127
Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 200 (1) , 51-55
Improvement in Depression Scores After 1 Hour of Light Therapy Treatment in Patients With Seasonal Affective Disorder
The purpose of this study was to investigate possible rapid effects of light therapy on depressed mood in patients with seasonal affective disorder. Participants received 1 hour of bright light therapy and 1 hour of placebo dim red light in a randomized order crossover design. Depressed mood was measured at baseline and after each hour of light treatment using two self-report depression scales (Profile of Mood States–Depression-Dejection [POMS-D] subscale and the Beck Depression Inventory II [BDI-II]). When light effects were grouped for the two sessions, there was significantly greater reduction in self-report depression scores by −1.3 (p = 0.02) on the BDI-II and −1.2 (p = 0.02) on the POMS-D. A significant but modest improvement was detected after a single active light session. This is the first study, to our knowledge, to document an immediate improvement with light treatment using a placebo-controlled design with a clinical sample of depressed individuals.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 200 (1) , 51-55
Improvement in Depression Scores After 1 Hour of Light Therapy Treatment in Patients With Seasonal Affective Disorder
The purpose of this study was to investigate possible rapid effects of light therapy on depressed mood in patients with seasonal affective disorder. Participants received 1 hour of bright light therapy and 1 hour of placebo dim red light in a randomized order crossover design. Depressed mood was measured at baseline and after each hour of light treatment using two self-report depression scales (Profile of Mood States–Depression-Dejection [POMS-D] subscale and the Beck Depression Inventory II [BDI-II]). When light effects were grouped for the two sessions, there was significantly greater reduction in self-report depression scores by −1.3 (p = 0.02) on the BDI-II and −1.2 (p = 0.02) on the POMS-D. A significant but modest improvement was detected after a single active light session. This is the first study, to our knowledge, to document an immediate improvement with light treatment using a placebo-controlled design with a clinical sample of depressed individuals.